Factors to Consider in the Selection of Noninvasive Fibrosis Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease

Affiliations

• ¹ Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Herston, Australia.
• ² QIMR Berghofer Medical Research Institute, Brisbane, Australia.
• ³ Mater Research and Translational Research Institute, Brisbane, Australia; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, University of Queensland, Woolloongabba, Australia.
• ⁴ Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Herston, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Australia; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Australia; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, University of Queensland, Woolloongabba, Australia.
• ⁵ QIMR Berghofer Medical Research Institute, Brisbane, Australia; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, University of Queensland, Woolloongabba, Australia.
• ⁶ Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Herston, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Australia; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Australia; Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, University of Queensland, Woolloongabba, Australia. Electronic address: e.powell@uq.edu.au.